BridgeBio hosted a healthcare investor conference in Boston on August 27, 2025.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BridgeBio hosted a healthcare investor conference in Boston on August 27, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Boston
capital and largest city of Massachusetts, United States
-
BridgeBio
company in Palo Alto, United States
Related events
- Ligand Pharmaceuticals Incorporated participated in investor conferences in New York and Boston on August 26, 2026.
- Investor conferences are scheduled in Boston, and the company advises investors to follow updates via LinkedIn.
- Boston city government provided funding to local health centers.
- CEO Jacek Olczak is scheduled to address investors at a conference in Boston.
Coverage
Newest first; wire copies grouped- GlobeNewswireBridgeBio to Participate in September Investor Conferences PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of bio